Author:
Lewden Charlotte,Drabo Youssoufou J,Zannou Djimon M,Maiga Moussa Y,Minta Daouda K,Sow Papa S,Akakpo Jocelyn,Dabis François,Eholié Serge P,
Funder
The National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH)
International Epidemiologic Databases to Evaluate AIDS (IeDEA)
National Institutes of Health
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference54 articles.
1. Determinants of survival following HIV-1 seroconversion after the introduction of HAART;CASCADE Collaboration;Lancet,2003
2. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries;The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration, The Antiretroviral Therapy (ART) Cohort Collaboration;Lancet,2006
3. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study;Laurent;AIDS,2002
4. Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis;Seyler;AIDS Res Hum Retroviruses,2007
5. UNAIDS Global report UNAIDS Report on the global AIDS epidemic 2013 [Internet] 2013 http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献